CancerLinQ?

Wishing you a wonderful Employee Appreciation Day! We truly appreciate each member of our team. Thank you for your hard work and dedication!

The ACCC 51st Annual Meeting and Cancer Center Business Summit is in full swing here in Washington, DC! We’re thrilled to be part of this incredible event. Visit us at table #8 to see firsthand how CancerLinQ can transform your practice. Discover how we streamline QOPI/ASCO Certification, enhance quality care, identify targeted therapies, and unlock valuable insights into cancer patient populations. #AMCCBS25 #Oncology #JoinUs #InnovationInCancerCareCare

We are looking forward to the ACCC 51st Annual Meeting and Cancer Center Business Summit in Washington, DC, from March 5-7! Join us at Booth #8 to discover how CancerLinQ can transform your practice by streamlining QOPI/ASCO Certification, enhancing the quality of care, identifying novel targeted therapies, and uncovering valuable insights about cancer patient populations. Schedule a meeting: https://hubs.ly/Q038FPkv0 #AMCCBS25 #Oncology #JoinUs

Catch us in the exhibit hall in Booth # 8 at the 51st Association of Cancer Care Centers Business Summit, and connect with us and oncology care providers from around the country as we explore the latest cancer care trends in business, technology, and policy. Meet with us at ACCC to get a peek at the data and technology innovations that will overcome oncology practice challenges: https://hubs.ly/Q037zzwD0 #AMCCBS25 #Oncology #JoinUs

Check out the latest blog post by Jeff Elton, PhD, and Robert Miller, MD, discussing the rising cancer burden and oncologist shortage in the U.S. The American Cancer Society predicts over 2 million new cancer diagnoses by 2025, with rates climbing, especially among women. Meanwhile, a shortage of oncology professionals threatens care access. Urgent solutions like better reimbursement, enhanced training, and innovative tech, including Generative AI, are needed to support clinicians. Check out the blog: https://hubs.ly/Q035f7250 #HealthcareInnovation #CancerAwarenessareness

Our own Dr. Robert Miller weighs in in this white paper published by Clinical Research Data Sharing Alliance. We are proud to serve in this important effort to make the best and most ethical use of data to further research and treatment options to benefit cancer care for all. #RWD #realworlddata #clinicaltrials

Join us as Louis Culot, General Manager of CancerLinQ at ConcertAI, takes us on a journey through the groundbreaking ways CancerLinQ is transforming cancer care. By harnessing the power of data, CancerLinQ is making it easier for healthcare providers to navigate the complexities of cancer care. Deployed across the U.S. in academic centers, community clinics, and large health systems, this innovative platform is enhancing treatment decisions and improving patient outcomes. With tools like the SmartLinQ portal, integrated seamlessly with electronic medical records, doctors receive crucial alerts right when they need them most! This means more informed decisions at critical points in a patient's treatment journey. Technologies like RxLink and TriaLinQ empower healthcare professionals to identify patients who are eligible for new therapies and clinical trials—addressing a pressing issue: only 7% of patients currently access these vital opportunities. By analyzing disparities in cancer care, CancerLinQ is committed to driving concordant care, ensuring that every patient receives the best possible treatment tailored to their unique needs. Let's support a future where cancer care is not just a battle, but a journey informed by data and compassion! Learn more about CancerLinQ: https://hubs.ly/Q02Md1b80 #CancerCare #DataDriven #HealthInnovation #ClinicalTrials #PatientOutcomes #ConcertAI #FightCancer #HealthcareTransformation

Learn how CancerLinQ, a ConcertAI initiative, is revolutionizing cancer care by utilizing electronic health data to improve quality and drive discovery. In this video, see how the SmartLinQ application integrates oncology practice data from multiple sites to provide decision support at the point of care. Clinics rely on quality programs like COPI and ASCO certified to maintain high standards. Stay ahead of the curve with SmartLinQ's actionable patient feature, updated regularly to help doctors track new therapies, biomarkers, and patient eligibility in real time. And now, with the addition of TriaLinQ, part of ConcertAI's Digital Trial Solutions, practices can easily screen patients for clinical trials and seamlessly transition new sites with minimal IT integration. View our video showcase to learn more: https://hubs.ly/Q02Lm8yz0 #CancerCare #DigitalHealth #Innovation #SmartLinQ

Our Patient Match capabilities are designed to help streamline your work and drive impactful results. To give you a closer look at what TriaLinQ can offer, we've put together a comprehensive factsheet. This factsheet dives deep into the features, benefits, and potential impact that TriaLinQ can have on your clinical trial processes. Request to download the factsheet: https://hubs.ly/Q02KMN6r0 #Innovation #Research #TriaLinQ #PatientMatch #ClinicalTrials

Today is World Lung Cancer Day, a day dedicated to raising awareness about the impact of lung cancer. In honor of this important day, we want to highlight a recent study done by AstraZeneca and the Cleveland Clinic using the CancerLinQ Discovery database. The researchers investigated the prevalence of EGFR mutations in early-stage non-small-cell lung cancer (NSCLC) patients and the treatments they received in routine clinical practice. EGFR mutations can impact treatment decisions, especially for patients with stage IB–IIIA NSCLC. Findings show that only 21.6% of patients underwent EGFR mutation testing, highlighting the importance of testing for personalized treatment plans. Learn more: https://hubs.ly/Q02JKNzN0 #LungCancerResearch #EGFRmutations #PersonalizedMedicine #WLCD24 #WorldLungCancerDay